About Proof Diagnostics
Proof Diagnostics is a company based in Cambridge (United States) founded in 2020 by Omar Abudayyeh, Feng Zhang, and Jonathan Gootenberg was acquired by Ginkgo Bioworks in February 2024. Proof Diagnostics operates in a competitive market with competitors including Curative, Pictor, Biolidics, FluroTech and Aptitude Medical, among others.
- Headquarter Cambridge, United States
- Founders Omar Abudayyeh, Feng Zhang, Jonathan Gootenberg
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Ginkgo Bioworks
(Feb 28, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Proof Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Proof Diagnostics
Detailed funding history for Proof Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Proof Diagnostics
Proof Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ginkgo Bioworks.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Gene editing-based cultured ingredients are provided for agriculture.
|
Locked | Locked | Locked |
Investor details for Proof Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proof Diagnostics
Investment portfolio details for Proof Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proof Diagnostics
Detailed financials for Proof Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proof Diagnostics Comparisons
Peer comparison for Proof Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proof Diagnostics
Proof Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, Pictor, Biolidics, FluroTech and Aptitude Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Immunodiagnostic products are developed via multiplexed assays.
|
|
| Locked | Locked | Locked |
Cell enrichment systems are provided for cancer diagnosis and treatment.
|
|
| Locked | Locked | Locked |
Smart devices for in-house cannabis and hemp testing are provided.
|
|
| Locked | Locked | Locked |
Provider of at-home COVID and COVID/Flu tests
|
Detailed competitors of Proof Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proof Diagnostics
Complete news archive for Proof Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proof Diagnostics
Proof Diagnostics was founded in 2020.
Proof Diagnostics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Proof Diagnostics, founded in 2020 in Cambridge, United States, focuses on life sciences, infectious diseases, in vitro diagnostic tests, viral, and sars-cov-2. Manufacturer of CRISPR based Covid-19 molecular testing device. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Proof Diagnostics has 1 investor. Key investors include Ginkgo Bioworks.